NM_000446.7:c.498-101C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000446.7(PON1):c.498-101C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0712 in 1,098,950 control chromosomes in the GnomAD database, including 3,743 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.096 ( 953 hom., cov: 32)
Exomes 𝑓: 0.067 ( 2790 hom. )
Consequence
PON1
NM_000446.7 intron
NM_000446.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.169
Publications
8 publications found
Genes affected
PON1 (HGNC:9204): (paraoxonase 1) This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017]
PON1 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 7-95308312-G-A is Benign according to our data. Variant chr7-95308312-G-A is described in ClinVar as Benign. ClinVar VariationId is 1243112.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0957 AC: 14546AN: 152072Hom.: 948 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14546
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0672 AC: 63634AN: 946760Hom.: 2790 AF XY: 0.0660 AC XY: 32202AN XY: 488278 show subpopulations
GnomAD4 exome
AF:
AC:
63634
AN:
946760
Hom.:
AF XY:
AC XY:
32202
AN XY:
488278
show subpopulations
African (AFR)
AF:
AC:
3822
AN:
22438
American (AMR)
AF:
AC:
7138
AN:
38864
Ashkenazi Jewish (ASJ)
AF:
AC:
1554
AN:
22716
East Asian (EAS)
AF:
AC:
3975
AN:
34560
South Asian (SAS)
AF:
AC:
4851
AN:
71966
European-Finnish (FIN)
AF:
AC:
2714
AN:
40928
Middle Eastern (MID)
AF:
AC:
251
AN:
3626
European-Non Finnish (NFE)
AF:
AC:
36134
AN:
668260
Other (OTH)
AF:
AC:
3195
AN:
43402
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3112
6224
9335
12447
15559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1218
2436
3654
4872
6090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0958 AC: 14574AN: 152190Hom.: 953 Cov.: 32 AF XY: 0.0963 AC XY: 7170AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
14574
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
7170
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
6973
AN:
41498
American (AMR)
AF:
AC:
1924
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
225
AN:
3468
East Asian (EAS)
AF:
AC:
613
AN:
5174
South Asian (SAS)
AF:
AC:
345
AN:
4832
European-Finnish (FIN)
AF:
AC:
730
AN:
10602
Middle Eastern (MID)
AF:
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3536
AN:
68004
Other (OTH)
AF:
AC:
179
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
647
1294
1941
2588
3235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
353
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.